Skip to Content

Most Viewed

  • Review
  • Open Access
372 Citations
111,358 Views
15 Pages

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review

  • Amber N. Edinoff,
  • Haseeb A. Akuly,
  • Tony A. Hanna,
  • Carolina O. Ochoa,
  • Shelby J. Patti,
  • Yahya A. Ghaffar,
  • Alan D. Kaye,
  • Omar Viswanath,
  • Ivan Urits and
  • Adam M. Kaye
  • + 2 authors

5 August 2021

Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the global population. Despite an array of treatment modalities, depressive disorders remain difficult to manage due to many factors. Beginning with the introductio...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
302 Citations
73,806 Views
14 Pages

Benzodiazepines: Uses, Dangers, and Clinical Considerations

  • Amber N. Edinoff,
  • Catherine A. Nix,
  • Janice Hollier,
  • Caroline E. Sagrera,
  • Blake M. Delacroix,
  • Tunde Abubakar,
  • Elyse M. Cornett,
  • Adam M. Kaye and
  • Alan D. Kaye

10 November 2021

Benzodiazepines (BZDs) are among one of the most widely prescribed drug classes in the United States. BZDs are a class of psychoactive drugs known for their depressant effect on the central nervous system (CNS). They quickly diffuse through the blood...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
8 Citations
56,627 Views
18 Pages

Cognitive Effects of Cannabis Use: A Comprehensive Review Across Domains

  • Andréia Pucinelli de Souza Queiroz,
  • Maria Olivia Pozzolo Pedro,
  • Marcela Waisman Campos,
  • Julio Torales,
  • Antonio Ventriglio and
  • João Mauricio Castaldelli-Maia

Cannabis is the most widely consumed illicit substance worldwide, with rising use particularly among adolescents and young adults. Accumulating evidence indicates that chronic cannabis use may negatively impact several domains of cognition, yet findi...

  • Review
  • Open Access
50 Citations
41,076 Views
16 Pages

Chronic Administration of Melatonin: Physiological and Clinical Considerations

  • Donald Givler,
  • Amy Givler,
  • Patrick M. Luther,
  • Danielle M. Wenger,
  • Shahab Ahmadzadeh,
  • Sahar Shekoohi,
  • Amber N. Edinoff,
  • Bradley K. Dorius,
  • Carlo Jean Baptiste and
  • Alan D. Kaye
  • + 2 authors

15 March 2023

Background: Exogenous melatonin is commonly used to treat insomnia, other sleep problems, and numerous medical illnesses, including Alzheimer’s disease, autism spectrum disorder, and mild cognitive impairment in adults and children. There is ev...

  • Review
  • Open Access
103 Citations
35,769 Views
17 Pages

Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges

  • Amber N. Edinoff,
  • Sarah E. Kaufman,
  • Janice W. Hollier,
  • Celina G. Virgen,
  • Christian A. Karam,
  • Garett W. Malone,
  • Elyse M. Cornett,
  • Adam M. Kaye and
  • Alan D. Kaye

8 November 2021

Catatonia is a syndrome that has been associated with several mental illness disorders but that has also presented as a result of other medical conditions. Schizophrenia and other psychiatric disorders such as mania and depression are known to be ass...

  • Review
  • Open Access
43 Citations
33,745 Views
19 Pages

Anesthetic Considerations for Patients on Psychotropic Drug Therapies

  • Monica W. Harbell,
  • Catalina Dumitrascu,
  • Layne Bettini,
  • Soojie Yu,
  • Cameron M. Thiele and
  • Veerandra Koyyalamudi

29 November 2021

Psychotropic drugs are used in the treatment of psychiatric and non-psychiatric conditions. Many patients who are on psychotropic medications may present for procedures requiring anesthesia. Psychotropic medications can have dangerous interactions wi...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
44 Citations
29,013 Views
16 Pages

Chronic Pain Treatment Strategies in Parkinson’s Disease

  • Amber Edinoff,
  • Niro Sathivadivel,
  • Timothy McBride,
  • Allyson Parker,
  • Chikezie Okeagu,
  • Alan D. Kaye,
  • Adam M. Kaye,
  • Jessica S. Kaye,
  • Rachel J. Kaye and
  • Ivan Urits
  • + 2 authors

18 November 2020

Neurological disorders, including Parkinson’s disease (PD), have increased in prevalence and are expected to further increase in the coming decades. In this regard, PD affects around 3% of the population by age 65 and up to 5% of people over th...

  • Review
  • Open Access
38 Citations
28,192 Views
54 Pages

Migraine: Advances in the Pathogenesis and Treatment

  • Horia Pleș,
  • Ioan-Alexandru Florian,
  • Teodora-Larisa Timis,
  • Razvan-Adrian Covache-Busuioc,
  • Luca-Andrei Glavan,
  • David-Ioan Dumitrascu,
  • Andrei Adrian Popa,
  • Andrei Bordeianu and
  • Alexandru Vlad Ciurea

31 August 2023

This article presents a comprehensive review on migraine, a prevalent neurological disorder characterized by chronic headaches, by focusing on their pathogenesis and treatment advances. By examining molecular markers and leveraging imaging techniques...

(This article belongs to the Special Issue Migraines and Beyond: Advances in the Pathogenesis and Treatment of Chronic Headache Disorders)
  • Review
  • Open Access
27 Citations
27,656 Views
30 Pages

Effective postoperative pain management remains a major clinical challenge in spinal surgery, with poorly controlled pain affecting up to 50% of patients and contributing to delayed mobilization, prolonged hospitalization, and risk of chronic postsur...

(This article belongs to the Section Pain Research)
  • Review
  • Open Access
38 Citations
26,524 Views
11 Pages

The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review

  • Elisa E. Neuchat,
  • Brooke E. Bocklud,
  • Kali Kingsley,
  • William T. Barham,
  • Patrick M. Luther,
  • Shahab Ahmadzadeh,
  • Sahar Shekoohi,
  • Elyse M. Cornett and
  • Alan D. Kaye

Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders, characterized by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is marked by symptoms such...

  • Review
  • Open Access
29 Citations
25,822 Views
14 Pages

Bremelanotide for Treatment of Female Hypoactive Sexual Desire

  • Amber N. Edinoff,
  • Nicole M. Sanders,
  • Kyle B. Lewis,
  • Tucker L. Apgar,
  • Elyse M. Cornett,
  • Adam M. Kaye and
  • Alan D. Kaye

4 January 2022

Hypoactive sexual desire disorder (HSDD) is a persistent deficiency or absence of sexual fantasies and desire resulting in significant distress or interpersonal difficulty. Women with this disorder may display a lack of motivation for sexual activity...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Brief Report
  • Open Access
5 Citations
25,567 Views
7 Pages

Internal Tremor in Long COVID May Be a Symptom of Dysautonomia and Small Fiber Neuropathy

  • Svetlana Blitshteyn,
  • Ilene S. Ruhoy,
  • Lauren R. Natbony and
  • David S. Saperstein

Background/Objectives: Internal tremor (IT) is often reported by patients with post-acute sequelae of SARS-CoV-2, also known as Long COVID, as a distressing and disabling symptom. Similarly, physicians are typically perplexed by the nature and etiolo...

  • Review
  • Open Access
57 Citations
24,123 Views
21 Pages

The Management of Intracranial Aneurysms: Current Trends and Future Directions

  • Aviraj S. Deshmukh,
  • Stefano M. Priola,
  • Aris H. Katsanos,
  • Gianluca Scalia,
  • Aderaldo Costa Alves,
  • Abhilekh Srivastava and
  • Christine Hawkes

3 January 2024

Intracranial aneurysms represent a major global health burden. Rupture of an intracranial aneurysm is a catastrophic event. Without access to treatment, the fatality rate is 50% in the first 30 days. Over the last three decades, treatment approaches...

(This article belongs to the Special Issue Global Burden of Neurological Disorder)
  • Review
  • Open Access
7 Citations
23,479 Views
12 Pages

Ergogenic and Sympathomimetic Effects of Yohimbine: A Review

  • Sophia L. Porrill,
  • Rebecca R. Rogers and
  • Christopher G. Ballmann

12 December 2024

The purpose of this review is to compile and discuss available evidence in humans on the efficacy of YHM supplementation on performance in different exercise modalities. Yohimbine (YHM) is a naturally occurring alkaloid that induces increases in symp...

  • Review
  • Open Access
47 Citations
23,473 Views
18 Pages

Mild-to-Moderate Traumatic Brain Injury: A Review with Focus on the Visual System

  • Steven H. Rauchman,
  • Jacqueline Albert,
  • Aaron Pinkhasov and
  • Allison B. Reiss

Traumatic Brain Injury (TBI) is a major global public health problem. Neurological damage from TBI may be mild, moderate, or severe and occurs both immediately at the time of impact (primary injury) and continues to evolve afterwards (secondary injur...

  • Article
  • Open Access
132 Citations
23,452 Views
11 Pages

20 December 2022

This study sought to ascertain the prevalence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) among a sample of 465 patients with Long COVID. The participants completed three questionnaires: (1) a new questionnaire measuring both the f...

  • Systematic Review
  • Open Access
37 Citations
22,226 Views
33 Pages

Mindfulness-Based Interventions and the Hypothalamic–Pituitary–Adrenal Axis: A Systematic Review

  • Hernando Vargas-Uricoechea,
  • Alejandro Castellanos-Pinedo,
  • Karen Urrego-Noguera,
  • Hernando D. Vargas-Sierra,
  • María V. Pinzón-Fernández,
  • Ernesto Barceló-Martínez and
  • Andrés F. Ramírez-Giraldo

20 November 2024

Background: Numerous studies have evaluated the effect that mindfulness-based interventions (MBIs) have on multiple health outcomes. For its part, stress is a natural response to environmental disturbances and within the associated metabolic response...

  • Review
  • Open Access
12 Citations
21,901 Views
19 Pages

Mucuna pruriens, a Possible Treatment for Depressive Disorders

  • Alfonso Mata-Bermudez,
  • Araceli Diaz-Ruiz,
  • Luis Ricardo Silva-García,
  • Eduardo Manuel Gines-Francisco,
  • Roxana Noriega-Navarro,
  • Camilo Rios,
  • Héctor Alonso Romero-Sánchez,
  • Diego Arroyo,
  • Abraham Landa and
  • Luz Navarro

16 November 2024

Depression is a mental disorder that depicts a wide variety of symptoms, including mood and cognitive alterations, as well as recurrent thoughts of death or suicide. It could become the second leading cause of premature death or disability worldwide....

  • Review
  • Open Access
27 Citations
21,804 Views
13 Pages

Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks

  • Amber N. Edinoff,
  • Niroshan Sathivadivel,
  • Shawn E. McNeil,
  • Austin I. Ly,
  • Jaeyeon Kweon,
  • Neil Kelkar,
  • Elyse M. Cornett,
  • Adam M. Kaye and
  • Alan D. Kaye

3 January 2022

Pregnant women constitute a vulnerable population, with 25.3% of pregnant women classified as suffering from a psychiatric disorder. Since childbearing age typically aligns with the onset of mental health disorders, it is of utmost importance to cons...

  • Article
  • Open Access
30 Citations
20,543 Views
12 Pages

RETRACTED: Effect Comparison of E-Cigarette and Traditional Smoking and Association with Stroke—A Cross-Sectional Study of NHANES

  • Urvish Patel,
  • Neel Patel,
  • Mahika Khurana,
  • Akshada Parulekar,
  • Amrapali Patel,
  • Juan Fernando Ortiz,
  • Rutul Patel,
  • Eseosa Urhoghide,
  • Anuja Mistry and
  • Shamik Shah
  • + 4 authors

Introduction: Tobacco use is one of the most significant risk factors for stroke. Besides traditional cigarettes and combustible products, the use of e-cigarettes and electronic nicotine delivery products has been widespread among young adults in the...

  • Review
  • Open Access
22 Citations
20,356 Views
18 Pages

Scientific Rationale for the Treatment of Cognitive Deficits from Long COVID

  • Arman Fesharaki Zadeh,
  • Amy F. T. Arnsten and
  • Min Wang

Sustained cognitive deficits are a common and debilitating feature of “long COVID”, but currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral prefrontal cortex (dlPFC) are the most consistently afflic...

  • Review
  • Open Access
36 Citations
19,794 Views
17 Pages

Background: Dementia, a significant cognitive impairment, is characterized by a decline in memory. It affects an individual’s mood and behavior, which can impair their quality of life and well-being. Studies show that the demand for applying mu...

  • Review
  • Open Access
6 Citations
18,959 Views
26 Pages

Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay–Sachs Disease

  • María González-Sánchez,
  • María Jesús Ramírez-Expósito and
  • José Manuel Martínez-Martos

Tay–Sachs disease (TSD) is a rare and severe neurodegenerative disorder inherited in an autosomal recessive manner. It is caused by a deficiency of the enzyme hexosaminidase A, which is responsible for the degradation of GM2 gangliosides—...

(This article belongs to the Section Movement Disorders and Neurodegenerative Diseases)
  • Review
  • Open Access
52 Citations
18,217 Views
13 Pages

1 October 2021

Serotonin-norepinephrine reuptake inhibitors (SNRIs) inhibit the presynaptic neuronal uptake of serotonin and norepinephrine and prolong the effects of the monoamines in the synaptic cleft within the central nervous system, leading to increased posts...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
32 Citations
18,073 Views
27 Pages

A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts

  • Maria Carolina Jurcau,
  • Anamaria Jurcau,
  • Razvan Gabriel Diaconu,
  • Vlad Octavian Hogea and
  • Vharoon Sharma Nunkoo

20 September 2024

Creutzfeldt-Jakob disease is a rare neurodegenerative and invariably fatal disease with a fulminant course once the first clinical symptoms emerge. Its incidence appears to be rising, although the increasing figures may be related to the improved dia...

  • Review
  • Open Access
14 Citations
18,019 Views
10 Pages

Lights on for Autism: Exploring Photobiomodulation as an Effective Therapeutic Option

  • Catherine Hamilton,
  • Ann Liebert,
  • Vincent Pang,
  • Pierre Magistretti and
  • John Mitrofanis

27 October 2022

Autism is a neurodevelopmental condition that starts in childhood and continues into adulthood. The core characteristics include difficulties with social interaction and communication, together with restricted and repetitive behaviours. There are a n...

(This article belongs to the Collection Advances in Neurodegenerative Diseases)
  • Review
  • Open Access
56 Citations
17,711 Views
16 Pages

Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects

  • Amber N. Edinoff,
  • Catherine A. Nix,
  • Amira S. Odisho,
  • Caroline P. Babin,
  • Alyssa G. Derouen,
  • Salim C. Lutfallah,
  • Elyse M. Cornett,
  • Kevin S. Murnane,
  • Adam M. Kaye and
  • Alan D. Kaye

22 August 2022

As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines. Flubromazolam(8-bromo-6-(2-fluorophenyl)-1-methyl-4H...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
15 Citations
17,172 Views
18 Pages

Post-Traumatic Cerebral Infarction: A Narrative Review of Pathophysiology, Diagnosis, and Treatment

  • Roy A. Poblete,
  • Charlotte Zhong,
  • Anish Patel,
  • Grace Kuo,
  • Philip Y. Sun,
  • Jiayu Xiao,
  • Zhaoyang Fan,
  • Nerses Sanossian,
  • Amytis Towfighi and
  • Patrick D. Lyden

4 January 2024

Traumatic brain injury (TBI) is a common diagnosis requiring acute hospitalization. Long-term, TBI is a significant source of health and socioeconomic impact in the United States and globally. The goal of clinicians who manage TBI is to prevent secon...

  • Review
  • Open Access
15 Citations
15,933 Views
13 Pages

Oxytocin, a Novel Treatment for Methamphetamine Use Disorder

  • Amber N. Edinoff,
  • Elliot Thompson,
  • Chandler E. Merriman,
  • Mark R. Alvarez,
  • E. Saunders Alpaugh,
  • Elyse M. Cornett,
  • Kevin S. Murnane,
  • Rachel L. Kozinn,
  • Mila Shah-Bruce and
  • Alan D. Kaye
  • + 1 author

30 January 2022

The treatment of substance abuse with oxytocin is a novel approach to a challenging public health issue that continues to contribute to a growing economic cost for societies worldwide. Methamphetamine addiction is one of the leading causes of mortali...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
48 Citations
15,114 Views
19 Pages

Pain Catastrophizing: How Far Have We Come

  • Katarina Simic,
  • Boris Savic and
  • Nebojsa Nick Knezevic

26 April 2024

The perception of pain is strongly influenced by various social, emotional, and cognitive factors. A psychological variable which has consistently been shown to exert its influence on pain is a cognitive process referred to as pain catastrophizing. N...

  • Systematic Review
  • Open Access
3 Citations
14,864 Views
13 Pages

11 November 2024

Background: Ventriculoperitoneal (VP) shunt therapy is a crucial intervention for normal-pressure hydrocephalus (NPH). This meta-analysis delves into survival time and the impact of baseline symptom burden on survival after VP shunt therapy for NPH,...

(This article belongs to the Collection Advances in Neurodegenerative Diseases)
  • Review
  • Open Access
56 Citations
14,784 Views
21 Pages

Long COVID, the Brain, Nerves, and Cognitive Function

  • Allison B. Reiss,
  • Caitriona Greene,
  • Christopher Dayaramani,
  • Steven H. Rauchman,
  • Mark M. Stecker,
  • Joshua De Leon and
  • Aaron Pinkhasov

SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who have been infected with COVID-19 and may be a result of viral-associated sy...

(This article belongs to the Special Issue COVID-19, Neuroinflammation and Therapeutics)
  • Review
  • Open Access
21 Citations
14,167 Views
16 Pages

Paliperidone to Treat Psychotic Disorders

  • Hormazd D. Minwalla,
  • Peter Wrzesinski,
  • Allison Desforges,
  • Joshua Caskey,
  • Brittany Wagner,
  • Patrick Ingraffia,
  • James C. Patterson,
  • Amber N. Edinoff,
  • Adam M. Kaye and
  • Ivan Urits
  • + 2 authors

28 July 2021

Purpose of Review: This is a comprehensive review of the literature regarding the use of paliperidone in the treatment of schizophrenia and schizoaffective disorder. It covers the background and presentation of schizophrenia and schizoaffective disor...

  • Review
  • Open Access
14 Citations
14,107 Views
21 Pages

Cannabinoids in Chronic Pain: Clinical Outcomes, Adverse Effects and Legal Challenges

  • Aleksandar Sic,
  • Conor George,
  • Daniela Ferrer Gonzalez,
  • Vasilis-Spyridon Tseriotis and
  • Nebojsa Nick Knezevic

5 September 2025

Cannabinoids have gained increasing attention as potential therapeutic agents in chronic pain management. Their mechanisms of action, mediated through CB1 and CB2 receptors, provide a pharmacological alternative to conventional analgesics. The eviden...

(This article belongs to the Section Pain Research)
  • Review
  • Open Access
4 Citations
13,908 Views
20 Pages

Aneurysmal subarachnoid hemorrhage (aSAH) is a severe neurocritical condition often complicated by cerebral vasospasm (CVS), leading to delayed cerebral ischemia (DCI) and significant morbidity and mortality. Despite advancements in management, thera...

  • Perspective
  • Open Access
39 Citations
13,486 Views
16 Pages

29 July 2024

Animal experimentation has long been a cornerstone of neurology research, but it faces growing scientific, ethical, and economic challenges. Advances in artificial intelligence (AI) are providing new opportunities to replace animal testing with more...

(This article belongs to the Collection Advances in Neurodegenerative Diseases)
  • Review
  • Open Access
42 Citations
13,201 Views
33 Pages

Alzheimer’s and Parkinson’s are the most common neurodegenerative diseases (NDDs). The development of aberrant protein aggregates and the progressive and permanent loss of neurons are the major characteristic features of these disorders....

(This article belongs to the Collection Advances in Neurodegenerative Diseases)
  • Systematic Review
  • Open Access
8 Citations
13,159 Views
16 Pages

Background: Peripheral facial paralysis (PFP) affects the facial nerve, the seventh cranial nerve. It has an incidence rate of 20–30 cases per 100,000 habitants. The diagnosis is clinical, though imaging tests may be required in some cases. The...

  • Review
  • Open Access
76 Citations
13,085 Views
18 Pages

Acute and Post-Acute Neurological Complications of COVID-19

  • Ali Al-Ramadan,
  • Omar Rabab’h,
  • Jawad Shah and
  • Abeer Gharaibeh

9 March 2021

Coronavirus disease 2019 (COVID-19) is an emerging global health emergency caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The global outbreak of SARS-CoV-2 infection has been declared a global pandemic...

  • Review
  • Open Access
60 Citations
13,068 Views
16 Pages

Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson’s Disease

  • Erjola Bej,
  • Patrizia Cesare,
  • Anna Rita Volpe,
  • Michele d’Angelo and
  • Vanessa Castelli

29 April 2024

Parkinson’s disease (PD) is a progressive neurodegenerative condition marked by the gradual deterioration of dopaminergic neurons in the substantia nigra. Oxidative stress has been identified as a key player in the development of PD in recent s...

(This article belongs to the Collection Advances in Neurodegenerative Diseases)
  • Review
  • Open Access
32 Citations
12,780 Views
19 Pages

Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations

  • Amber N. Edinoff,
  • Juliana M. Fort,
  • Joshua J. Woo,
  • Christopher D. Causey,
  • Caroline R. Burroughs,
  • Elyse M. Cornett,
  • Adam M. Kaye and
  • Alan D. Kaye

1 September 2021

The monoamine hypothesis of depression attributes the symptoms of major depressive disorders to imbalances of serotonin, noradrenaline, and dopamine in the limbic areas of the brain. The preferential targeting of serotonin receptor (SERT) by selectiv...

(This article belongs to the Special Issue Psychotropic Drug Therapies and Clinical Considerations in Modern Practice)
  • Review
  • Open Access
29 Citations
11,743 Views
16 Pages

14 February 2023

Several therapeutic agents for neurological disorders are usually not delivered to the brain owing to the presence of the blood–brain barrier (BBB), a special structure present in the central nervous system (CNS). Focused ultrasound (FUS) combi...

(This article belongs to the Collection Advances in Neurodegenerative Diseases)
  • Review
  • Open Access
30 Citations
11,646 Views
16 Pages

Processing Speed and Attentional Shift/Mental Flexibility in Patients with Stroke: A Comprehensive Review on the Trail Making Test in Stroke Studies

  • Anna Tsiakiri,
  • Foteini Christidi,
  • Dimitrios Tsiptsios,
  • Pinelopi Vlotinou,
  • Sofia Kitmeridou,
  • Paschalina Bebeletsi,
  • Christos Kokkotis,
  • Aspasia Serdari,
  • Konstantinos Tsamakis and
  • Konstantinos Vadikolias
  • + 1 author

23 January 2024

The Trail Making Test (TMT) is one of the most commonly administered tests in clinical and research neuropsychological settings. The two parts of the test (part A (TMT-A) and part B (TMT-B)) enable the evaluation of visuoperceptual tracking and proce...

  • Case Report
  • Open Access
16 Citations
11,489 Views
11 Pages

Post-Polio Syndrome Revisited

  • Michael Punsoni,
  • Nelli S. Lakis,
  • Michelle Mellion and
  • Suzanne M. de la Monte

13 April 2023

Post-polio syndrome (PPS) is characterized by recrudescence or worsening of motor neuron disease symptoms decades after recovery from acute paralytic poliovirus infection, i.e., poliomyelitis. PPS afflicts between 25% and 40% of poliomyelitis survivo...

  • Review
  • Open Access
7 Citations
11,415 Views
29 Pages

Cerebral venous thrombosis (CVT) is a rare and potentially critical cerebrovascular disease involving intracranial dural sinuses and veins. The diagnosis is a stepwise pathway starting from clinical suspicion and employing several neuroradiological t...

  • Review
  • Open Access
13 Citations
11,075 Views
17 Pages

13 September 2023

Migraine, a prevalent neurological condition and the third most common disease globally, places a significant economic burden on society. Despite extensive research efforts, the precise underlying mechanism of the disease remains incompletely compreh...

(This article belongs to the Special Issue Migraines and Beyond: Advances in the Pathogenesis and Treatment of Chronic Headache Disorders)
  • Review
  • Open Access
20 Citations
10,946 Views
18 Pages

Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature

  • Shitiz Sriwastava,
  • Ashish K. Shrestha,
  • Syed Hassan Khalid,
  • Mark A. Colantonio,
  • Divine Nwafor and
  • Samiksha Srivastava

19 November 2021

Background and Purpose: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China in December 2019. Symptoms range from mild flu-like symptoms to more severe presentations, including pneumonia, acute re...

(This article belongs to the Special Issue Fourth Brainstorming Research Assembly for Young Neuroscientists (BraYn))
  • Article
  • Open Access
3 Citations
10,717 Views
11 Pages

Background: This study examined the impact of age-adjusted cerebrospinal fluid (CSF) protein levels on clinical characteristics, disease severity, and outcomes in Guillain–Barré Syndrome (GBS) patients. Methods: This retrospective study...

  • Article
  • Open Access
1 Citations
10,539 Views
15 Pages

A Retrospective Study of Lateral Antebrachial Cutaneous Nerve Neuropathy: Electrodiagnostic Findings and Etiologies in 49 Cases

  • Vasudeva G. Iyer,
  • Lisa B. E. Shields,
  • Michael W. Daniels,
  • Yi Ping Zhang and
  • Christopher B. Shields

10 October 2024

Background: The lateral antebrachial cutaneous nerve (LACN) is the terminal sensory branch of the musculocutaneous nerve and is rarely entrapped or injured. This study describes the electrodiagnostic (EDX) findings and etiologies of LACN neuropathy....

XFacebookLinkedIn
Neurol. Int. - ISSN 2035-8377